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A B S T R A C T
Purpose
We assessed cancer survivors’ perceptions of the quality of their follow-up care.
Methods
We surveyed a population-based cohort of leukemia, bladder, and colorectal cancer survivors
diagnosed 2 to 5 years previously in northern California (N  623; participation rate, 69.2%; overall
response rate, 49.2%). Data were collected between April 2003 and November 2004. Ten scales
assessed survivors’ perceptions of different aspects of care in the last 12 months, and an eleventh
scale measured their overall ratings of care.
Results
On nine of the 11 scales, mean scores ranged from 88 to 97 on a 0 to 100 response format,
indicating very positive experiences. The two areas where quality perceptions were lower were
discussions about health promotion and the physician’s knowledge of the whole patient. In
adjusted analyses, those without private health insurance (P  .02) and Hispanic and Asian
survivors compared with whites (P  .001) reported worse timeliness of care. Survivors who had
multiple comorbidities reported better scores on timeliness of care (P  .01) and physicians’
knowledge (P  .05) than survivors without any comorbidity. Length of the patient-physician
relationship was the variable most consistently found to be significantly associated with survivors’
quality assessments. Physicians’ information exchange had the strongest relationship with overall
ratings of care, followed by physicians’ affective behavior, their knowledge of the survivor, and
survivors’ perceptions of coordination of care (P  .001 for all).
Conclusion
Delivery of quality follow-up care to cancer survivors may require efforts to improve patient-
centered communication and coordination. Special emphasis may need to be placed on health
promotion discussions and adoption of a whole-person orientation.
J Clin Oncol 29:1280-1289. © 2011 by American Society of Clinical Oncology
INTRODUCTION
Cancer survivors require substantial follow-up care
to monitor for disease recurrence, to check for late
effects of treatment, and to manage ongoing symp-
toms and adverse effects.1 Other goals of follow-up
care include facilitating survivors’ psychosocial ad-
justment to their illness and promoting healthy life-
styles.2,3 Although the importance of follow-up care
has been recognized by clinicians, researchers, and
policy makers,4,5 systematic assessments of the qual-
ity of care delivered to cancer survivors are limited.6
Existing studies have typically focused on
understanding optimal models for delivering
follow-up care and on developing and evaluating
evidence-based guidelines for surveillance of cancer
survivors.7-12 More recently, attention has been
given to evaluating the role of care plans in facilitat-
ing the delivery of high-quality follow-up care.13
However, evaluation of the patient-centered aspects
of care such as survivors’ perspectives on access,
communication with health care professionals, and
perceptions of care coordination is virtually nonex-
istent.14 The few studies in oncology that have as-
sessed patient perspectives have typically focused on
the diagnosis and treatment phases of care.15-19 To
provide a more comprehensive picture of the quality
of follow-up care delivered to cancer survivors, sys-
tematic evaluations of the perspectives of survivors
are needed to complement efforts that focus on
more technical aspects of quality such as evaluation
of the concordance of follow-up care practices with
evidence-based guidelines.20-23
To better understand cancer survivors’ experi-
ences of receiving follow-up care, the National Can-
cer Institute sponsored the Assessment of Patient
Experiences of Cancer Care (APECC) study, a
population-based study of cancer survivors in
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northern California. This study had the following objectives: develop
and test a comprehensive survey to assess cancer survivors’ percep-
tions of the quality of their follow-up care; identify the sociodemo-
graphic, clinical, and follow-up care–related factors associated with
survivors’ quality-of-care assessments; and evaluate the association
between survivors’ assessments of the quality of individual aspects of
care with their overall ratings of care.
METHODS
Study Design
We recruited cancer survivors from the Cancer Prevention Institute of
California’s cancer registry, a member of National Cancer Institute’s Surveil-
lance, Epidemiology, and End Results program. To be eligible, survivors had to
read English; be diagnosed with leukemia or bladder or colorectal cancer
between June 1, 1999, and May 31, 2001 (ie, 2 to 5 years before enrolling onto
APECC); be at least 20 years old at diagnosis; have received cancer treatment;
have the cancer of interest as their first cancer diagnosis; not have any other
cancer between their initial diagnosis and the start of the study; and have no
objections from their physician of record to their participation. We focused on
leukemia and bladder and colorectal cancer because we wanted to test the
survey measures across multiple cancers that were applicable to both sexes and
individuals with a broad age range.
Figure 1 presents the study’s recruitment flowchart. On the basis of
information from the registry and physician consent, we identified 2,983
survivors to be potentially eligible for the study. We mailed them an initial
letter describing the study, informing them about a $25 participation incen-
tive, and indicating that an interviewer would call to screen them for eligibility.
Of the 2,492 survivors who were located and screened, 1,572 (63.1%) were
deemed eligible. Of these, 1,118 survivors agreed to participate and were
mailed a self-reported survey. Surveys were returned by 774 survivors; the
overall participation rate was 69.2% (774 of 1,118 survivors), and the overall
response rate was 49.2% (774 of 1,572 survivors). Of the 774 survivors who
provided data, 623 had received follow-up care in the last 12 months and
responded to items assessing patients’ care experiences. These 623 survivors
form our analytic sample. All data collection procedures took place between
April 2003 and November 2004. Study procedures were approved by the
Institutional Review Board of the Cancer Prevention Institute of California.
Survivors of leukemia, bladder, and colorectal cancers 
identified in the Greater Bay Area Registry who were 
diagnosed between June 1, 1999 and May 31, 2001 
(N = 3,927)















Participation rate: 774/1,118 = 69.2%
Response rate: 774/1,572 = 49.2%
Reported they had never been 
   diagnosed with cancer (14%)
Indicated they did not receive any 
   treatment  (4%)
Were deceased  (23%)
Sounded confused and/or 
   incoherent (6%)
Were too ill to participate (17%)







Fig 1. Recruitment flowchart for the Assessment of Patient Experiences of Cancer Care study. Six hundred twenty-three of 774 survivors received follow-up care in
the prior 12 months and formed the analytic sample for the study.
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Measures
We collected self-reported data on survivors’ sociodemographic charac-
teristics (age, sex, race/ethnicity, education, marital status, insurance status,
and residence in a medically underserved area), their clinical characteristics
(cancer type, perceived health status, number of comorbidities, years since
diagnosis, type of treatments received, and whether or not their cancer was in
remission), and several follow-up care–related variables (length of relationship
with physician, number of visits in the last 12 months, physician’s sex,
survivor-physician sex match, physician specialty, and setting of care).
The APECC survey included 33 items assessing survivors’ perceptions of
the quality of their follow-up care in the last 12 months. Of these 33 items, 30
were divided into 10 conceptually distinct scales measuring survivors’ experi-
ences in the following five broad areas: access to care (six items, three scales:
getting needed care, timeliness of care, and waiting time in physicians’ office);
interaction with physicians (17 items, three scales: information exchange,
affective behavior, and physicians’ knowledge); interaction with other mem-
bers of the health care team (four items, two scales: interaction with nurses and
interaction with office staff); discussion of health promotion (two items, one
scale); and perceptions of coordination of care (one item). The remaining
three items (one scale) assessed survivors’ overall ratings of their care (Table 2
provides the exact wording of all items).
Where possible, items were adapted from existing surveys including the
Consumer Assessment of Healthcare Providers and Systems surveys24-27 (11
items), the Primary Care Assessment Survey28-30 (four items), and the Ambu-
latory Care Experiences Survey31,32 (five items). Another two items were
adapted from a study of experiences of patients with colorectal cancer.15 In
addition, 11 new items were developed by the APECC investigators (noted in
Table 2). Although the wording of existing items was modified for relevance to
the context of follow-up care, we preserved their original response formats. A
majority of the items had one of the following four response options: not a
problem, a small problem, or a big problem; never, sometimes, usually, or
always; yes definitely, yes somewhat, or no; or poor, fair, good, very good, or
excellent. As suggested in other studies of patient experiences of care,15,16 for
descriptive purposes only, for each item, we considered a response of less than
the most positive option (ie, a response other than not a problem, always, yes
definitely, or excellent) to be an indicator of suboptimal quality. All items
underwent cognitive testing with nine cancer survivors (with diversity in age,
race, sex, and cancer type) to ensure that the questions and response options
were understandable and related to the concept being measured.
Data Analyses
To confirm the 10-factor/scale structure of the APECC items assessing
patient perspectives on individual aspects of follow-up care, we conducted a
confirmatory factor analysis using Mplus version 4.21 (Muthen & Muthen,
Los Angeles, CA). We evaluated the statistical fit of the 10-factor model to the
data using multiple fit indices, as follows: comparative fit index (CFI), the root
mean square error of approximation (RMSEA), and the standardized root
mean square residual (SRMR). Generally, CFI values greater than 0.95,
RMSEA values less than 0.06, and SRMR values less than 0.09 are considered to
indicate good model fit.33 The confirmatory factor analysis indicated a reason-
ably good fit for the 10-factor model (CFI  0.93, RMSEA  0.04, and
SRMR  0.04). Scores for all of these 10 variables and the overall ratings of care
variable were created by computing the mean of the scores on the individual
items comprising each variable. All scores were then linearly transformed to a
0 to 100 range, with a higher score representing more positive quality assess-
ments. All but two of the 10 multi-item scales had acceptable internal consis-
tency reliability (Cronbach’s   .75; details on score distribution are
presented in Table 3 and discussed later).
We examined the associations of various sociodemographic, clinical, and
follow-up care–related variables with survivors’ quality assessments by esti-
mating analysis of covariance models. Patient sex, residence in a medically
underserved area, remission status, and time since diagnosis were not associ-
ated in bivariate analyses with any of the variables assessing survivors’ quality
perceptions (P .1) and were not considered for adjusted analyses. We did not
include physician specialty and treatment in our models because they were
highly correlated with cancer type (P  .001). Among the bladder cancer
survivors, 91% saw a urologist; all but two leukemia survivors saw a hematol-
ogist/oncologist; and only colorectal cancer survivors saw physicians of differ-
ent specialties (primary care physician, 15%; oncologist, 62%; other specialist,
23%). Similarly, a majority of bladder cancer survivors had surgery only
(74%), 89% of leukemia survivors had chemotherapy with or without radia-
tion, and 66% of colorectal cancer survivors had surgery and adjuvant therapy
(chemotherapy, radiation, or both). We conducted linear regression analysis
to examine the associations between the 10 variables assessing cancer survi-
vors’ perceptions of quality of individual aspects of care and their overall care
ratings. We controlled for all the sociodemographic, clinical, and follow-up
care–related variables analyzed in the analysis of covariance models. All mod-
els were estimated using SPSS version 14.0 (SPSS, Chicago, IL). P  .05 was
considered to be statistically significant.
RESULTS
Sample Description
Table 1 lists the various characteristics of our sample. Twenty-six
percent of participants were bladder cancer survivors, 60% were colo-
rectal cancer survivors, and 14% were leukemia survivors. Approxi-
mately half of survivors had more than one comorbidity, and 80%
received care from the same physician for more than 2 years. Com-
pared with the eligible nonrespondents, respondents were rela-
tively younger (P  .001) and were less likely to be bladder cancer
survivors and more likely to be survivors of colorectal cancer or
leukemia (P  .001). There were no differences between respon-
dents and nonrespondents regarding sex, race/ethnicity, or year of
diagnosis (data not shown).
Survivors’ Perceptions of Quality of Care
Table 2 lists the percentage of survivors who reported less than
optimal quality in response to the 33 APECC items. Reports of subop-
timal quality ranged from 4% to 77%. Although only 4% of survivors
reported problems with access to specialists, 33% reported that their
physician did not always encourage them to ask questions, 59% re-
ported limited or no discussion on health promotion and prevention
topics, and 77% indicated that their physician had less than excellent
knowledge of them as a person.
Table 3 lists the score distribution for the 10 variables assessing
survivors’ perceptions of quality of individual aspects of care as well as
their overall care ratings. With the exception of the health promotion
and physicians’ knowledge scales, all scores indicated very positive
care experiences.
Correlates of Survivors’ Quality Assessments
As shown in Table 4, older survivors, survivors who were married
or living as married, survivors who perceived themselves to be in better
health, and survivors who had been seeing the same physician for
more than 2 years had significantly more positive perceptions of
quality on multiple aspects of care. Survivors belonging to minority
racial/ethnic subgroups (P  .001) and those without private health
insurance (P  .02) reported worse experiences on timeliness of care.
Survivors who received care in a health maintenance organization
clinic reported less problems with timeliness of care (P  .05) and
waiting time (P  .001). With the exception of health promotion,
survivors’ perceptions of quality of care did not vary with type of
cancer. Survivors who had multiple comorbidities reported better
timeliness of care (P  .01) and greater physicians’ knowledge
(P  .05) than those who did not have any comorbidity.
Arora et al
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Association Between Assessments of Individual
Aspects of Care and Overall Ratings
As shown in Table 5, survivors’ assessments of the quality of
interactions with their physician (P  .001), nurses (P  .05), and
office staff (P  .001), as well their perceptions of care coordination
(P  .001), were significantly associated with their overall ratings of
care. The strongest association with overall ratings was observed for
information exchange. With the exception of getting needed care,
access-related variables were not significantly associated with overall
ratings; discussion of health promotion was also not significantly
associated with overall ratings.
DISCUSSION
Cancer survivors in our study had positive quality perceptions for
many aspects of their follow-up care. However, multiple areas for
improvement were also identified. The top five items where survivors
reported suboptimal quality were related to physician knowledge and
health promotion. More than 60% of survivors reported that their
physician lacked complete knowledge of how their quality of life had
been affected by their cancer and its treatment, and more than 75% of
survivors perceived their physician to have a less than ideal under-
standing of them as a person. To facilitate optimal patient outcomes,
the Institute of Medicine’s Cancer Care for the Whole Patient: Meeting
Psychosocial Health Needs report34 calls for clinicians to adopt a whole-
person orientation while interacting with patients. Survivors in our
study perceived this to be an area for improvement. More than 50% of
survivors also reported suboptimal discussion of things they could do
to maintain healthy lifestyles and prevent future illnesses. Although
Table 1. Demographics, Clinical Characteristics, and Follow-Up
Care–Related Variables of Cancer Survivors














High school or less 20.9
Some college 31.4
College degree 20.3







Married/living as married 71.5
Other 28.5





























Surgery plus chemotherapy or radiation 35.1
Surgery plus chemotherapy and radiation 12.3
Chemotherapy with or without radiation
but no surgery 13.9




(continued in next column)
Table 1. Demographics, Clinical Characteristics, and Follow-Up
Care–Related Variables of Cancer Survivors (continued)























Abbreviation: HMO, health maintenance organization.
The other category in race/ethnicity consists of non-Hispanic blacks
(n  32), non-Hispanic American Indians or Alaskan natives (n  12), and
non-Hispanic Pacific Islanders (n  1), who were all grouped together
because of small numbers.
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Table 2. Survey Items, Response Options, and Survivors Reporting Less Than Optimal Quality of Care
Construct and Item Content Response Format
% of Survivors
Reporting Suboptimal
Quality (N  623)
Access-related items
Getting needed care
How much of a problem, if any, was it to get the follow-up cancer care that
you or a doctor believed was necessary?
Not a problem,† a small problem, a big
problem
5.3
How much of a problem, if any, was it to see a specialist that you needed
to see to get follow-up cancer care?




How often did you get an appointment for follow-up cancer care with your
doctor as soon as you wanted? Never, sometimes, usually, always 21.0
When you called your doctor’s office or clinic during regular office hours
with cancer-related questions, how often did you get the help or advice
you needed? Never, sometimes, usually, always 20.4
Waiting time in physician’s office
How many minutes late did your appointments with your doctor for follow-
up cancer care usually begin?
On time,  15 minutes, 16-30 minutes,
31-45 minutes,  45 minutes
26.4
When you went to see your doctor for follow-up cancer care, how much of
a problem was the wait before you got to see the doctor?‡





How often did your follow-up care doctor listen carefully to you? Never, sometimes, usually, always 15.5
How often did your follow-up care doctor explain things in a way you could
understand? Never, sometimes, usually, always 19.1
How often did your follow-up care doctor show respect for what you had to
say? Never, sometimes, usually, always 13.3
How often did your follow-up care doctor encourage you to ask all the
cancer-related questions you had?‡ Never, sometimes, usually, always 32.5
How often did your follow-up care doctor answer your cancer-related
questions to your satisfaction?‡ Never, sometimes, usually, always 22.9
How often did your follow-up care doctor make sure that you understood all
the information he or she gave you?‡ Never, sometimes, usually, always 25.7
How often did your follow-up care doctor spend enough time with you? Never, sometimes, usually, always 26.0
How often did you feel rushed by your follow-up care doctor?‡ Never, sometimes, usually, always 17.3
How often did your follow-up care doctor give you as much cancer-related
information as you wanted?‡ Never, sometimes, usually, always 28.2
How often did you leave your follow-up care doctor’s office or clinic with
unanswered questions related to your cancer? Never, sometimes, usually, always 17.5
Physicians’ affective behavior
How often did your follow-up care doctor treat you with respect? Never, sometimes, usually, always 9.6
How often was your follow-up care doctor caring and kind? Never, sometimes, usually, always 13.0
How often did your follow-up care doctor show a genuine interest in you as
a person?‡ Never, sometimes, usually, always 20.5
How often was your follow-up care doctor sensitive to your feelings and
emotions?‡ Never, sometimes, usually, always 23.3
Physicians’ knowledge
How would you rate your follow-up care doctor’s knowledge of your
medical history? Poor, fair, good, very good, excellent 43.5
How would you rate your follow-up care doctor’s knowledge of your
responsibilities at home, work, or school? Poor, fair, good, very good, excellent 76.5
How would you rate your follow-up care doctor’s knowledge of how cancer
and the medical treatments you received for cancer have affected the
quality of your life?‡ Poor, fair, good, very good, excellent 60.8
Health care team items
Interaction with nurses
How often did nurses at your follow-up care doctor’s office or clinic treat
you with courtesy and respect?‡ Never, sometimes, usually, always 17.4
How often were the nurses at your follow-up care doctor’s office or clinic
as helpful as you thought they should be?‡ Never, sometimes, usually, always 25.9
Interactions with office staff
How often did office staff at your follow-up care doctor’s office or clinic
treat you with courtesy and respect? Never, sometimes, usually, always 23.7
How often was office staff at your follow-up care doctor’s office or clinic as
helpful as you thought they should be? Never, sometimes, usually, always 31.7
(continued on following page)
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disease prevention and enhancement of well-being have been identi-
fied as essential components of survivorship care,4 our data suggest
that communication about health promotion during follow-up care
visits is limited.
There were several other areas of follow-up care where at least
one in four survivors reported suboptimal quality that could be targets
for improvement. These included delays in start of appointments,
perceived lack of care coordination among the care team, less than
ideal help provided by the office staff, and experiences of subopti-
mal information exchange with the physician. These reports sug-
gest that to deliver optimal follow-up care, quality improvement
efforts would need to focus not only on behaviors of individual
physicians and health care team members, but also on redesigning
workflow in the office practice to improve efficiency, communica-
tion, and coordination.
Consistent with existing studies, older survivors reported more
positive experiences, whereas survivors who perceived their health to
be poorer reported worse experiences.35 Contrary to our expectations,
survivors with more comorbidities reported better timeliness of care
and physician knowledge. It is possible that cancer survivors who live
with multiple comorbidities have more intense interactions with the
health care system, making them more experienced consumers. Sup-
port for this assertion is also obtained from our finding that survivors
who had more contact with their providers in terms of number of
visits also reported more positive experiences on timeliness of care and
physician knowledge. It is also possible that given busy practices,
Table 2. Survey Items, Response Options, and Survivors Reporting Less Than Optimal Quality of Care (continued)
Construct and Item Content Response Format
% of Survivors
Reporting Suboptimal
Quality (N  623)
Health promotion
Did your follow-up care doctor or someone from your doctor’s office or clinic
talk with you about specific things you could do to improve your health
or prevent illness? Yes, definitely; yes, somewhat; no 59.2
Did your follow-up care doctor or someone from your doctor’s office or clinic
give you the help you wanted to make changes in habits or lifestyle that
would improve your health or prevent illness? Yes, definitely; yes, somewhat; no 61.2
Coordination of care
In your opinion, how often did your follow-up care doctor, the nurses, and
other staff at your follow-up care doctor’s office or clinic seem to work
well together as a team? Never, sometimes, usually, always 28.4
Overall rating of care
Overall, how would you rate your follow-up care doctor? 0 (worst doctor possible), 2-9, 10 (best
doctor possible)
44.4
Based on your interactions with your doctor, nurses, and other staff, how
would you rate the quality of care you received from your follow-up care
doctor’s office or clinic? Poor, fair, good, very good, excellent 39.5
Would you recommend your follow-up care doctor’s office or clinic to your
family members and friends if they needed cancer-related care?
Definitely yes, probably yes, not sure,
probably not, definitely not 17.0
All items have a reference period of the last 12 months.
†Any response other than the response in italics was considered suboptimal.
‡Item developed by the Assessment of Patient Experiences of Cancer Care study team.
Table 3. Score Distribution of Cancer Survivors’ Reports and Rating Scales
Scale
Score
Cronbach’s  % Floor % Ceiling Skewness KurtosisMean SD
Getting needed care 96.9 13.4 .76 1.0 93.2 5.2 29.2
Timeliness of care 89.2 22.3 .62 2.4 74.4 2.4 5.3
Waiting time in physician’s office 88.2 21.1 .65 0.8 70.4 1.9 3.2
Information exchange 90.0 15.8 .92 0.0 47.8 2.2 5.1
Physicians’ affective behavior 92.2 17.1 .92 0.3 71.4 2.9 8.8
Physicians’ knowledge 72.1 24.9 .86 0.6 20.1 0.9 0.1
Interaction with nurses 91.2 16.7 .82 0.0 72.2 2.1 4.3
Interaction with office staff 88.1 20.5 .90 1.0 66.7 2.0 3.8
Health promotion 50.7 42.1 .88 33.9 33.4 0.1 1.6
Coordination of care 89.0 19.0 — 0.6 71.6 1.7 3.1
Overall rating of care 90.4 15.1 .87 0.0 46.8 2.3 6.0
NOTE: All scores were linearly transformed to a 0 to 100 scale.
Abbreviation: SD, standard deviation.
Coordination of care was measured by a single item.
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 50 89.7 72.6 78.8 80.7 84.2 62.9 80.8 78.1 48.8 77.6 80.7
50-64 88.1 75.6 86.7 82.8 86.6 59.4 85.0 80.6 49.4 81.7 81.7
65-74 90.1 75.6 92.1 83.0 86.5 62.9 88.4 86.9 46.4 86.0 84.3
 75 91.8 79.5 90.5 87.0 91.4 71.4 91.1 87.8 52.0 89.0 87.1
P .11 .16  .001  .05  .05 .001 .001 .001 .78 .001  .01
Education
High school or less 90.4 75.1 89.0 85.2 87.9 64.1 87.3 83.8 49.7 85.1 83.7
Some college 91.0 76.7 88.2 85.1 89.0 65.9 86.9 84.2 53.9 84.9 84.9
College degree 89.4 75.8 87.4 80.2 83.8 60.4 84.6 83.3 44.9 80.6 81.8
Graduate school 88.9 75.7 83.4 83.0 88.0 66.3 86.5 82.2 48.1 83.7 83.5
P .47 .93 .10 .04 .07 .20 .65 .85 .36 .25 .41
Race/ethnicity
NH white 91.3 81.3 86.5 85.3 88.3 65.2 87.2 84.1 45.9 83.9 85.3
Hispanic 89.7 74.4 85.2 83.4 86.8 65.0 84.7 80.8 53.7 81.9 82.9
NH Asian 91.2 66.4 89.1 81.2 85.2 59.5 84.4 80.4 47.2 82.5 80.6
NH other 87.5 81.2 87.3 83.6 88.5 67.0 89.0 88.1 49.8 86.0 85.1
P .37  .001 .77 .24 .57 .35 .45 .22 .71 .74 .10
Marital status
Married/living as married 91.7 77.8 89.6 85.0 87.2 64.9 87.2 84.7 48.9 84.8 83.5
Other 88.2 73.8 84.4 81.7 87.2 63.5 85.5 82.0 49.4 82.4 83.4
P  .01  .05 .01  .05 .98 .56 .32 .17 .90 .20 .92
Insurance
Private 91.3 78.8 88.5 83.4 88.3 65.3 86.2 84.6 48.5 83.5 84.1
Government only/none 88.5 72.8 85.5 83.3 86.0 63.0 86.4 82.1 49.8 83.6 82.9
P .08 .02 .22 .96 .26 .44 .92 .30 .80 .96 .50
Health status
Poor 93.4 68.6 90.0 73.5 84.5 50.8 82.6 81.0 37.3 77.0 78.6
Fair 87.2 73.9 86.0 82.8 85.1 61.6 84.6 82.1 49.0 81.5 81.8
Good 89.9 75.9 86.0 83.0 85.9 61.5 85.0 84.2 52.2 84.0 82.1
Very good 91.7 81.3 86.5 88.4 89.2 69.6 89.0 83.1 51.8 86.2 87.0
Excellent 87.5 79.5 86.6 89.2 91.2 77.3 90.3 86.6 55.5 89.1 87.9
P  .05  .05 .97  .001 .09  .001 .07 .67 .68 .08  .01
Cancer type
Bladder 89.8 76.4 88.4 83.6 86.8 61.2 85.1 80.7 39.0 82.0 82.8
Colorectal 91.3 74.7 87.1 83.8 87.2 64.1 85.9 83.4 55.4 82.7 83.0
Leukemia 88.7 76.3 85.5 82.6 87.5 67.2 87.9 85.9 53.1 86.1 84.5
P .24 .65 .62 .84 .96 .21 .52 .17 .001 .30 .70
No. of comorbidities
0 88.1 71.4 85.9 81.7 85.5 60.7 85.2 81.9 44.2 80.9 81.2
1 89.8 74.2 86.8 83.1 86.0 64.7 86.9 82.8 45.8 85.2 84.5
2 90.7 76.7 88.7 83.0 88.4 62.4 86.0 83.8 52.1 82.9 83.1
 3 91.0 81.0 86.7 85.6 88.8 68.9 87.2 84.9 54.5 85.2 85.2
P .36  .01 .76 .27 .33 .05 .78 .71 .22 .22 .15
Length of relationship, years
 1 84.7 69.1 81.2 79.0 81.5 60.5 82.6 79.8 42.7 79.6 78.9
1-2 90.4 77.5 91.9 85.5 88.6 65.1 85.6 84.2 58.0 84.2 84.4
 2 94.7 80.8 87.9 85.6 91.2 67.0 90.7 86.9 46.8 86.9 87.1
P  .001 .001  .05  .05 .001 .21  .01 .05 .14  .05 .001
No. of visits in last year
1 89.6 71.6 88.4 82.4 86.7 59.2 85.7 83.7 49.5 84.0 82.1
2-3 90.4 77.8 88.2 82.8 86.4 63.3 85.6 84.5 46.8 82.7 83.4
 4 89.7 78.0 84.4 84.8 88.4 70.0 87.7 81.9 51.2 84.1 85.0
P .80 .01 .12 .33 .48 .001 .42 .40 .58 .69 .22
(continued on following page)
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clinicians tend to selectively pay more attention to their patients who
have a greater cumulative disease burden. More studies are needed to
disentangle the reasons for the intriguing association between disease
burden and patient perceptions of quality.
Consistent with existing studies, Hispanic and non-Hispanic
Asian survivors reported worse scores on timeliness of care than non-
Hispanic white survivors.15,36-38 Given that survivors who did not
have private health insurance also reported worse experiences with
obtaining timely care suggests the potential for disparities in access to
follow-up care between potentially underserved populations of survi-
vors, such as minorities, the uninsured, and the underinsured, and the
rest of survivors. Post hoc analysis exploring the interaction effect of
race/ethnicity and insurance status on timeliness of care revealed a
nonsignificant interaction, suggesting that being of a minority race/
ethnicity and being uninsured or underinsured may be independent
risk factors for not receiving timely care. The impact of not receiving
timely follow-up care on patient outcomes needs to be explored.
Survivors who had been receiving care from the same physician
for more than 2 years reported more positive experiences on all but
two quality indicators compared with survivors who knew their phy-
sician for less than a year. A longer tenure of the patient-physician
relationship may result in better understanding of patient needs by the
physician, thus resulting in more positive experiences.39 It is also
possible that more positive evaluations among survivors who knew
their physician for a longer time are a reflection of a halo effect where
survivors are more likely to ignore lapses in quality from a physician
with whom they have established a long-term relationship than from
one who they do not know well. Length of the patient-physician
relationship and quality-of-care perceptions are likely to mutually
influence each other, and their relationship can be better teased out
within the context of longitudinal study designs.
Perceived quality of information exchange between physicians
and survivors had the strongest relationship with overall ratings of
care, followed by physicians’ affective behavior, physicians’ knowledge
of the survivor, and survivors’ perceptions of coordination of care.
These associations further highlight the importance of optimizing the
various functions of patient-physician communication as well as com-
munication among the various members of the health care team.40
Interestingly, although survivors reported limited communication re-
lated to health promotion, such lack of communication did not have
any impact on their overall ratings. These findings suggest that
although clinicians may not be devoting adequate time during
follow-up care visits to facilitating healthy lifestyles among survivors,
cancer survivors themselves may not be expecting such discussions.






















Male 90.6 77.6 86.2 84.1 87.9 67.4 86.5 83.5 52.8 85.4 86.4
Female 89.2 74.0 87.8 82.6 86.5 61.0 86.1 83.2 45.5 81.7 80.6
P .38 .13 .51 .42 .47  .05 .86 .90 .16 .10 .001
Patient-physician sex match
Match 90.5 75.8 86.7 83.7 87.4 66.7 86.5 83.6 52.3 83.6 83.7
No match 89.4 75.8 87.2 83.1 87.0 61.6 86.1 83.2 46.0 83.6 83.3
P .32 1.00 .77 .66 .79 .02 .77 .84 .10 .97 .74
Setting of care
Doctor’s office 89.5 76.9 86.7 83.0 86.7 64.6 86.1 85.9 43.4 84.3 83.3
Hospital clinic 89.1 72.3 81.6 83.4 88.3 65.1 87.6 82.8 52.0 84.4 83.9
HMO clinic 91.2 78.3 92.7 83.7 86.6 62.8 85.2 81.4 52.0 82.0 83.2
P .37  .05  .001 .91 .58 .72 .50 .08 .07 .50 .90
Model R2 0.13 0.21 0.14 0.12 0.10 0.16 0.09 0.08 0.07 0.10 0.14
NOTE. Patient sex, residence in a medically underserved area, remission status, and time since diagnosis were not significant in bivariate analyses (P  .1) and
were not considered for adjusted analyses in the analysis of covariance models. A higher score indicates more positive quality assessments.
Abbreviations: NH, non-Hispanic; HMO, health maintenance organization.
Race/ethnicity was coded such that any respondent who indicated to be Hispanic was coded as such; whites, Asians, and others represent NH whites, NH Asians,
and NH others, respectively. The other group consists of blacks, American Indians, Pacific Islanders, and those who indicated multiple races; they were all grouped
together as a result of small numbers.
Table 5. Association of Survivors’ Quality Assessment of Individual
Aspects of Follow-Up Care With Overall Ratings of Care
Independent Variable B SE 95% CI P
Getting needed care 0.08 0.03 0.02 to 0.14  .01
Timeliness of care 0.03 0.02 0.01 to 0.07 .17
Waiting time 0.03 0.02 0.07 to 0.07 .11
Information exchange 0.25 0.04 0.16 to 0.34  .001
Affective behavior 0.14 0.04 0.06 to 0.21  .001
Physician knowledge 0.14 0.02 0.10 to 0.18  .001
Interaction with nurses 0.06 0.03 0.00 to 0.12 .05
Interaction with office staff 0.09 0.03 0.04 to 0.14 .001
Health promotion 0.00 0.01 0.02 to 0.02 .98
Coordination of care 0.10 0.03 0.06 to 0.15  .001
NOTE. Linear regression model controlled for survivors’ age, education,
race/ethnicity, marital status, insurance status, health status, type of cancer,
number of comorbid conditions, length of relationship with physician, number
of visits in past year, physician sex, sex match between survivor and
physician, and setting of care. Model R2  0.70.
Abbreviation: B, unstandardized regression coefficient.
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Whether survivors’ lack of expectation about health promotion dis-
cussions might be driven by a lack of awareness of the importance of
healthy behaviors to their overall health or is a result of their health
promotion needs being met by sources other than their follow-up care
physician is not clear and needs further exploration.
Our findings should be interpreted in the light of potential limi-
tations. The most important limitation is the cross-sectional nature of
the study. Causal implications cannot be inferred from the significant
associations reported in this study; findings need to be replicated
within the context of longitudinal study designs. We recruited partic-
ipants from a population-based sample of leukemia, bladder, and
colorectal cancer survivors in Northern California. Our findings may
not be generalizable to survivors of other common cancers such as
breast and prostate cancer or to survivors in other parts of the United
States. Further validation of the APECC measures in other cancer
survivor populations is needed. Although we were able to compare the
experiences of Hispanic and non-Hispanic Asian survivors with those
of non-Hispanic white survivors, we could not do the same for non-
Hispanic African American survivors because of the small size of the
African American subgroup in our sample.
Despite potential limitations, the APECC study provides unique
data on the follow-up care experiences of cancer survivors. With the
aging of the population and the dissemination of effective therapeutic
interventions in oncology, the ranks of cancer survivors are likely to
increase substantially in the future. Efforts at optimizing quality of care
delivered to these survivors in the future should focus not only on the
technical aspects but also on the patient-centered aspects of care. The
APECC study lays the foundation for systematic evaluations of
patient-centeredness of follow-up care provided to cancer survivors in
the United States.
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